Cargando…

Tumor-derived GCSF Alters Tumor and Systemic Immune System Cell Subset Composition and Signaling

While immunotherapies such as immune checkpoint blockade and adoptive T-cell therapy improve survival for a subset of human malignancies, many patients fail to respond. Phagocytes including dendritic cells (DC), monocytes, and macrophages (MF) orchestrate innate and adaptive immune responses against...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matos, Israel, Barvalia, Maunish, Chehal, Manreet K., Robertson, A. Gordon, Kulic, Iva, Silva, Jessica A.F.D., Ranganathan, Abhinandan, Short, Amy, Huang, Yu-Hsuan, Long, Erin, Priatel, John J., Dhanji, Salim, Nelson, Brad H., Krebs, Danielle L., Harder, Kenneth W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997410/ https://www.ncbi.nlm.nih.gov/pubmed/36911097 http://dx.doi.org/10.1158/2767-9764.CRC-22-0278

Ejemplares similares

Granulocyte colony-stimulating factor (GCSF) fused with Fc Domain produced from E. coli is less effective than Polyethylene Glycol-conjugated GCSF
por: Do, Bich Hang, et al.
Publicado: (2017)

Expression of granulocyte colony stimulating factor (GCSF) in Hansenula polymorpha
por: Talebkhan, Yeganeh, et al.
Publicado: (2016)

Extension of human GCSF serum half-life by the fusion of albumin binding domain
por: Nikravesh, Fatemeh Yadavar, et al.
Publicado: (2022)

Production of PEGylated GCSF from Non-classical Inclusion Bodies Expressed in Escherichia coli
por: Trinh, Nguyen Thi My, et al.
Publicado: (2021)

Gender-Specific Mechanism of Synaptic Impairment and Its Prevention by GCSF in a Mouse Model of ALS
por: Naumenko, Nikolay, et al.
Publicado: (2011)

Fulminate anaerobic bacteremia after chemotherapy for metastatic breast cancer despite the prophylactic use of GCSF
por: Petrova, Mila, et al.
Publicado: (2010)

Predictive modeling of the outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (MONITOR-GCSF study)
por: Aapro, M., et al.
Publicado: (2016)

Implantation of a Poly-l-Lactide GCSF-Functionalized Scaffold in a Model of Chronic Myocardial Infarction
por: Spadaccio, Cristiano, et al.
Publicado: (2017)

Impaired mitophagy in Fanconi anemia is dependent on mitochondrial fission
por: Shyamsunder, Pavithra, et al.
Publicado: (2016)

Efficient Process Development of Recombinant Human Granulocyte Colony-Stimulating Factor (rh-GCSF) Production in Escherichia coli
por: Babaeipour, Valiollah, et al.
Publicado: (2015)

G-CSF utilization rate and prescribing patterns in United States: associations between physician and patient factors and GCSF use
por: Barnes, Gisoo, et al.
Publicado: (2014)

Am80‐GCSF synergizes myeloid expansion and differentiation to generate functional neutrophils that reduce neutropenia‐associated infection and mortality
por: Li, Lin, et al.
Publicado: (2016)

Is There Additive Therapeutic Effect When GCSF Combined with Adipose-Derived Stem Cell in a Rat Model of Acute Spinal Cord Injury?
por: Min, Joongkee, et al.
Publicado: (2017)

Investigation of the pH-dependent aggregation mechanisms of GCSF using low resolution protein characterization techniques and advanced molecular dynamics simulations
por: Ko, Suk Kyu, et al.
Publicado: (2022)

Specifically differentiated T cell subset promotes tumor immunity over fatal immunity
por: Ramadan, Abdulraouf, et al.
Publicado: (2017)

Phase 1/2 Study of the Timing and Efficacy of 3 mg Peg-GCSF in Neo/Adjuvant Dose Dense Breast Cancer Treatment Protocols
por: Patel, Amol, et al.
Publicado: (2023)

Changes and prognostic values of tumor-infiltrating lymphocyte subsets after primary systemic therapy in breast cancer
por: Ahn, Soomin, et al.
Publicado: (2020)

IL-8, IL-10, TGF-β, and GCSF Levels Were Increased in Severe Persistent Allergic Asthma Patients with the Anti-IgE Treatment
por: Yalcin, Arzu D., et al.
Publicado: (2012)

Over- and under-prophylaxis for chemotherapy-induced (febrile) neutropenia relative to evidence-based guidelines is associated with differences in outcomes: findings from the MONITOR-GCSF study
por: Bokemeyer, Carsten, et al.
Publicado: (2017)

Experimental systems to study the origin of the myofibroblast in peritoneal fibrosis
por: Padwal, Manreet, et al.
Publicado: (2016)

Characterization of tumor infiltrating Natural Killer cell subset
por: Levi, Inbar, et al.
Publicado: (2015)

Human γδT-cell subsets and their involvement in tumor immunity
por: Wu, Dang, et al.
Publicado: (2017)

Tumor-Associated Macrophage Subsets: Shaping Polarization and Targeting
por: Zhang, Qindong, et al.
Publicado: (2023)

2431: Characterization of immune cell differences with anti-thymocyte globulin (ATG) and granulocyte colony stimulating factor (GCSF) in both preclinical and clinical models of type 1 diabetes
por: Lin, Andrea, et al.
Publicado: (2018)

Impaired CD8 T cell memory and CD4 T cell primary responses in IL-7Rα mutant mice
por: Osborne, Lisa C., et al.
Publicado: (2007)

Monocyte Subsets: Phenotypes and Function in Tuberculosis Infection
por: Sampath, Pavithra, et al.
Publicado: (2018)

Treatment patterns and outcomes in patients with non‐small cell lung cancer receiving biosimilar filgrastim for prophylaxis of chemotherapy‐induced/febrile neutropaenia: Results from the MONITOR‐GCSF study
por: Aapro, Matti, et al.
Publicado: (2019)

The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker Study
por: Anpalakhan, Shobana, et al.
Publicado: (2023)

A Subset of Malignant Mesothelioma Tumors Retain Osteogenic Potential
por: Lansley, S. M., et al.
Publicado: (2016)

Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset
por: Agnoletto, Chiara, et al.
Publicado: (2019)

Fibroblast Subsets in Intestinal Homeostasis, Carcinogenesis, Tumor Progression, and Metastasis
por: Dang, Hao, et al.
Publicado: (2021)

Dendritic cell subsets in cancer immunity and tumor antigen sensing
por: Del Prete, Annalisa, et al.
Publicado: (2023)

Mechanisms for Recognition of Tumor Antigens and Mediation of Anti‐tumor Effect by Noncytolytic Lyt‐2(+) T Cell Subset
por: Sakamoto, Kohichi, et al.
Publicado: (1988)

SMAC is expressed de novo in a subset of cervical cancer tumors
por: Espinosa, Magali, et al.
Publicado: (2004)

Characterization of tumor-associated B-cell subsets in patients with colorectal cancer
por: Shimabukuro-Vornhagen, Alexander, et al.
Publicado: (2014)

EGFRvIII Is Expressed in Cellular Areas of Tumor in a Subset of Glioblastoma
por: NOZAWA, Takanori, et al.
Publicado: (2019)

Arg1 expression defines immunosuppressive subsets of tumor-associated macrophages
por: Arlauckas, Sean P., et al.
Publicado: (2018)

Identification of tumor‐associated macrophage subsets that are associated with breast cancer prognosis
por: Strack, Elisabeth, et al.
Publicado: (2020)

T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
por: Jiang, Hua, et al.
Publicado: (2021)

Characterization of Immune Cell Subsets of Tumor Infiltrating Lymphocytes in Brain Metastases
por: Croft, Priyakshi Kalita-de, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pgcqq4qklmlmrnj4nqkgu94t4g